3 items including Dopamine cells critical in sugar/sweetener choice, leading to a higher likelihood of sugar consumption later (Obesity / Weight Loss / Fitness News From Medical News Today)

Dopamine cells critical in sugar/sweetener choice, leading to a higher likelihood of sugar consumption later (09/24/13 08:00:00 UTC)

The results of the new study imply that it is hard to fool the brain by providing it with 'energyless' sweet flavours. Our pleasure in consuming sweet solutions is driven to a great extent by the amount of energy it provides: greater reward in the brain is attributed to sugars compared to artificial sweeteners...

Free Newsfeed to Email gateway

Unsubscribe

A new way to prevent overweight and obesity - primary weight maintenance (09/24/13 07:00:00 UTC)

The same message to everyone does not work if the goal is to prevent overweight and obesity in the population. It is also important to reach groups normally considered as being at low risk for gaining weight. This is what Kristina Lindvall shows in her doctoral thesis at Umea University, Sweden...

Free Newsfeed to Email gateway

Unsubscribe

Norgine and Takeda announce the new drug application approval of Oblean (cetilistat) tablets 120mg in Japan (09/24/13 09:00:00 UTC)

Norgine and Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approved the New Drug Application (NDA) of OBLEAN Tablets 120mg for the treatment of obesity with complications. OBLEAN is a lipase inhibitor discovered by UK-based Alizyme Therapeutics Limited. Norgine acquired all rights to the product from Alizyme in October 2009...

Free Newsfeed to Email gateway

Unsubscribe